NEW YORK and LONDON, August 10, 2017 (GLOBE NEWSWIRE) — Akari Therapeutics (NASDAQ: AKTX), an emerging growth, clinical-stage biopharmaceutical company, announced today that Clive Richardson, Chief Operations Officer, and Dr. Wynne Weston-Davies, Medical Director, will present at the 37th Annual Canaccord Genuity Growth Conference on August 10th, 2017, in Boston, Massachusetts. The company is scheduled to present at 2:00 p.m. EST.